Stuart Kupfer

21PUBLICATIONS

97CO-AUTHORS

PharmacogenomicsToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Molecular targetsMedical virology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 08, 2026

Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.

|Mar 05, 2026

Clinical Evaluation of Drug-Drug Interactions With Aficamten.

Neha Maharao, Donghong Xu, Punag Divanji

|Mar 04, 2026

Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study.

Albree Tower-Rader, Ahmad Masri, Michael E Nassif

|Mar 02, 2026

Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial.

Alberto Foà, Muthiah Vaduganathan, Brian L Claggett

|Mar 02, 2026

Dipstick proteinuria and outcomes in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF.

Ryohei Ono, Misato Chimura, Kieran F Docherty

|Mar 02, 2026

Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF.

Misato Chimura, Kieran F Docherty, Pardeep S Jhund

Pageof 4

Frequent Collaborators

10 joint publications

Fady I Malik

Stephen B Heitner

Scott D Solomon

Ahmad Masri

Marco Metra

Roberto Barriales-Villa

Brian L Claggett

Tyrell Simkins

Jeremy M Shefner

Gary Michael Felker

Frequent Collaborators

10 joint publications

Fady I Malik

9 joint publications

Stephen B Heitner

5 joint publications

Scott D Solomon

5 joint publications

Ahmad Masri